Georgia Karpathiou1, Marie-Laurie Stachowitz2, Jean Marc Dumollard2, Marie Gavid3, Marios Froudarakis4, Jean Michel Prades3, Michel Peoc'h2. 1. Department of Pathology, North Hospital, University Hospital of St-Etienne, Saint-Étienne, France gakarpath@yahoo.gr. 2. Department of Pathology, North Hospital, University Hospital of St-Etienne, Saint-Étienne, France. 3. Department of Head and Neck Surgery, North Hospital, University Hospital of St-Etienne, Saint-Étienne, France. 4. Department of Pneumonology, North Hospital, University Hospital of St-Etienne, Saint-Étienne, France.
Abstract
BACKGROUND/AIM: In metastatic head and neck squamous cell carcinoma (HNSCC) the metastatic tumor does not always keep the same gene expression profile as the parental tumor, which may influence the course of the disease. The aim of this study was to compare the expression of genes implicated in HNSCC carcinogenesis between the primary tumor and the corresponding lymph node metastasis. MATERIALS AND METHODS: Eighteen HNSCC, their corresponding node metastases and non-neoplastic tissues were studied by RT-qPCR for the expression of EGFR, VEGF, claudin7, maspin, survivin and SCCA. The levels of expression were correlated with histological characteristics and patients' prognosis. RESULTS: All genes except for survivin displayed different expression in node metastasis compared to the primary tumor. The expression of EGFR, survivin, maspin, and claudin7 in node metastasis and SSCA in the primary tumor affected the prognosis. SCCA expression is associated with the expression of claudin7 and maspin. P16-positive tumors expressed low levels of VEGF and SCCA, while keratinizing tumors over-expressed VEGF. CONCLUSION: Differential gene expression levels in node metastases compared to the primary tumor is linked to the prognosis of HNSCC patients. The histological/immunohisto-chemical characteristics of the tumor are associated with these genes expression changes. Copyright
BACKGROUND/AIM: In metastatic head and neck squamous cell carcinoma (HNSCC) the metastatic tumor does not always keep the same gene expression profile as the parental tumor, which may influence the course of the disease. The aim of this study was to compare the expression of genes implicated in HNSCC carcinogenesis between the primary tumor and the corresponding lymph node metastasis. MATERIALS AND METHODS: Eighteen HNSCC, their corresponding node metastases and non-neoplastic tissues were studied by RT-qPCR for the expression of EGFR, VEGF, claudin7, maspin, survivin and SCCA. The levels of expression were correlated with histological characteristics and patients' prognosis. RESULTS: All genes except for survivin displayed different expression in node metastasis compared to the primary tumor. The expression of EGFR, survivin, maspin, and claudin7 in node metastasis and SSCA in the primary tumor affected the prognosis. SCCA expression is associated with the expression of claudin7 and maspin. P16-positive tumors expressed low levels of VEGF and SCCA, while keratinizing tumors over-expressed VEGF. CONCLUSION: Differential gene expression levels in node metastases compared to the primary tumor is linked to the prognosis of HNSCC patients. The histological/immunohisto-chemical characteristics of the tumor are associated with these genes expression changes. Copyright
Authors: Yun-Sung Lim; Yong Jun Choi; Bo Hae Kim; Hee-Bok Kim; Chang Gun Cho; Seok-Won Park; Joo Hyun Park Journal: In Vivo Date: 2020 May-Jun Impact factor: 2.155
Authors: Ewelina Gumbarewicz; Przemko Tylżanowski; Jarogniew Łuszczki; Joanna Kałafut; Arkadiusz Czerwonka; Justyna Szumiło; Anna Wawruszak; Krzysztof Kupisz; Krzysztof Polberg; Jolanta Smok-Kalwat; Andrzej Stepulak Journal: Am J Cancer Res Date: 2021-06-15 Impact factor: 6.166
Authors: Charles R Schutt; Hua Sun; Jaya Sarin Pradhan; Yvonne Saenger; Jessica Ley; Douglas Adkins; Matthew Ingham; Li Ding; Brian A Van Tine Journal: Oncotarget Date: 2021-03-16